三重阴性乳腺癌中的血管生成和免疫微环境:有针对性的治疗
Ying Zhang1, Hao Yang1, Yanhong Jiang1
1Department of Pathophysiology, School of Medicine, Nantong University, Jiangsu 226001, China.
概括
三阴性乳腺癌 (TNBC) 是具有很少向治疗的侵袭性. 结合免疫疗法和向治疗,如TGF-β和IL-1β抑制剂,为患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限向治疗选择的侵袭性亚型.
- 化疗是标准的,但像免疫检查点抑制剂这样的免疫疗法显示出希望.
- 瘤免疫微环境 (TIME) 显著影响TNBC的进展和免疫逃避.
研究的目的:
- 探索 TIME 在 TNBC 进展和免疫逃脱中的作用.
- 审查TNBC目前和新兴的治疗策略.
- 突出结合疗法的潜力,以改善患者的治疗结果.
主要方法:
- 关于TNBC,TIME和治疗干预的当前文献的综述.
- 分析TAMs和MDSCs对免疫抑制有所贡献的机制.
- 对组合策略的临床试验数据的评估.
主要成果:
- TNBC的进展与瘤血管生成和免疫抑制细胞 (TAMs,MDSCs) 等因素有关.
- 组合疗法 (抗血管性+免疫检查点抑制剂) 显示出协同效应.
- 新型向疗法 (TGF-β,IL-1β抑制剂) 提供了新的治疗途径.
结论:
- 在TNBC发育和免疫逃避中,TIME至关重要.
- 结合免疫疗法和向治疗的组合策略对TNBC有希望.
- 结合这些模式的个性化医疗方法为TNBC患者提供了新的希望.
更多相关视频
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
8.7K
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
2.5K
相关概念视频
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
